DS
FMTX

David Shaw’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

David Shaw’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,010
Closed -$319K – 5568
2022
Q3 		$319K Sell
16,010
-66,485
-81% -$877K ﹤0.01% 4268
2022
Q2 		$568K Buy
82,495
+69,183
+520% +$486K ﹤0.01% 4020
2022
Q1 		$124K Buy
+13,312
New +$142K ﹤0.01% 4966

David Shaw's FMTX Position: Q4 2022 in Review

David Shaw sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 16,010 shares — an estimated $319K sold.

David Shaw first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $568K in Q2 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • David Shaw reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 16,010 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $319K.
  • David Shaw first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • David Shaw's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $568K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.